NCT06581653View on ClinicalTrials.gov

Medication Adherence to Phone-supervised Pancreatic Enzyme Replacement Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

October 10, 2025

Study Completion Date

December 30, 2025

Conditions
Chronic PancreatitisPancreatic Exocrine Insufficiency
Interventions
BEHAVIORAL

Phone-based PERT education intervention

Participants who allocate to the intervention group will receive regular phone-based PERT education intervention by professional team.

Trial Locations (1)

Unknown

Changhai Hostipal, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER

NCT06581653 - Medication Adherence to Phone-supervised Pancreatic Enzyme Replacement Therapy | Biotech Hunter | Biotech Hunter